GSTM1 and chronic obstructive pulmonary disease: Except the loss of enzymatic GST activity that might be a result of the deletion polymorphisms in GSTM1 and/or GSTT1, in COPD, there is increased production of ROS [5,6], which will additionally contribute to LTL shortening.